China Clinical Chemistry and Immunodiagnostic Market Size, Growth and Analysis | Industry Forecast Report- 2019-2023

Citation
Title:
China Clinical Chemistry and Immunodiagnostic Market Size, Growth and Analysis | Industry Forecast Report- 2019-2023
Author:
Year: 
Publication: 
Volume: 
Issue: 
Start Page: 
End Page: 
Publisher: 
Language: 
English
URL: 
http://www.marketreportsonchina.com/marketreports/2019-2023-china-immunodiagnostic-market-supplier-shares-and-strategies-volume-and-sales-forecasts-technology-and-inst/1354955
Select license: 
Select License
DOI: 
PMID: 
ISSN: 
Abstract:

Market Reports on China Provides the Trending Market Research Report on “2019-2023 China Immunodiagnostic Market: Supplier Shares and Strategies, Volume and Sales Forecasts, Technology and Instrumentation Review” under Diagnostics Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

This new report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report provides specimen, test volume and sales forecasts; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.

Request a free sample copy of Immunodiagnostic Market Report @
http://www.marketreportsonchina.com/marketreports/Sample/Reports/1354955

Rationale

The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

 

Tests Analyzed in the Report:

Routine Clinical Chemistry

Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Total, BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose, HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus, Potassium, Protein, Total, Sodium, Triglycerides, Troponin, Uric Acid.

 

Therapeutic Drug Monitoring (TDM)

Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam,

Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin.

 

Endocrine Function

Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, PO Ab, TSH.

 

Tumor Markers and Special Chemistry

AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid), Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood, PAP, PSA, Thyroglobulin, Vitamin B-12.

 

Immunoproteins

C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM, Immunofixation, Prealbumin, Protein Electrophoresis.

 

Drugs of Abuse

Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene, Tricyclic Antidepressants.

 

Current and Emerging Products

- Analysis of current and emerging clinical chemistry and immunodiagnostic tests.

- Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers.

 

Technology Assessment

- Assessment of current and emerging technologies, and their potential market applications.

- Comprehensive lists of companies developing or marketing new technologies and products by test.

 

Strategic Recommendations

- New product development opportunities with significant market appeal.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

 

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Browse our full report with Table of Contents:
http://www.marketreportsonchina.com/marketreports/2019-2023-china-immunodiagnostic-market-supplier-shares-and-strategies-volume-and-sales-forecasts-technology-and-inst/1354955

 

About Market Reports on China:
Market Reports on China is thus the one-stop solution for the entire market research requirements with regards to China.
We provide you with insight and analysis on the country’s economic outlook at the national, regional and city level, presenting deep understanding of disparities and evolutionary paths. Get a complete, consistent and concise view of your markets with comprehensive industry reports. Our latest regional databanks, forecasts, and detailed risk ratings will help you to identify risk and opportunities in every industry and develop strategic plans to deal with the competitiveness in the Chinese market.

Contact us:
Market Reports on China
Tel: +91 22 27810772 / 27810773
Email:info@marketreportsonchina.com
Website: http://www.marketreportsonchina.com
Follow us on: Twitter, Facebook, LinkedIn

Comments
  • Recommend Us